Names | |
---|---|
Preferred IUPAC name
Quinolin-8-amine | |
Identifiers | |
| |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
ECHA InfoCard | 100.008.572 |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C9H8N2 | |
Molar mass | 144.177 g·mol−1 |
Appearance | pale yellow solid |
Density | 1.337 g/cm3[1] |
Melting point | 65 °C (149 °F; 338 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
8-Aminoquinoline is the 8-amino derivative of quinoline. Often abbreviated AQ, it is a pale yellow solid. It is structurally analogous to 8-hydroxyquinoline.[2]
The derivatives primaquine, tafenoquine and pamaquine have been tested for anti-malaria activity.[3][4] Primaquine is still used routinely worldwide as part of the treatment of Plasmodium vivax and Plasmodium ovale malaria, although how it prevents malarial recurrences is not, at present, clear.[5] Tafenoquine was approved for medical use in Australia and in the United States in 2018.[6][7]
The amine functional group is amenable to formation of amides, and thus can serve as a directing groupinorganic synthesis.[8][9]
The original synthesis of AQ involved nitration of quinoline to give a mixture of the 5- and 8-nitroderivatives, which were separated by distillation and sublimation. Reduction of the 8-nitro isomer with tin powder in the presence of hydrochloric acid gave the amines.[10] AQ can also be produced by amination of 8-chloroquinoline.
| |||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alveo- late |
| ||||||||||||||||||||||||||||||||||||||||||||||
Stramen- opile |
| ||||||||||||||||||||||||||||||||||||||||||||||
|